Cardiovascular disease and type 1 diabetes: prevalence, prediction and management in an ageing population
Open Access
- 19 August 2015
- journal article
- review article
- Published by SAGE Publications in Therapeutic Advances in Chronic Disease
- Vol. 6 (6) , 347-374
Abstract
Cardiovascular disease (CVD) is a major cause of mortality in type 1 diabetes mellitus (T1D). However, evidence of its risks and management is often extrapolated from studies in type 2 diabetic (T2D) patients or the general population. This approach is unsatisfactory given that the underlying pathology, demographics and natural history of the disease differ between T1D and T2D. Furthermore, with a rising life expectancy, a greater number of T1D patients are exposed to the cardiovascular (CV) risk factors associated with an ageing population. The aim of this review is to examine the existing literature around CVD in T1D. We pay particular attention to CVD prevalence, how well we manage risk, potential biomarkers, and whether the studies included the older aged patients (defined as aged over 65). We also discuss approaches to the management of CV risk in the older aged. The available data suggest a significant CVD burden in patients with T1D and poor management of CV risk factors. This is underpinned by a poor evidence base for therapeutic management of CV risk specifically for patients with T1D, and in the most relevant population – the older aged patients. We would suggest that important areas remain to be addressed, particularly exploring the risks and benefits of therapeutic approaches to CVD management in the older aged.Keywords
This publication has 129 references indexed in Scilit:
- Risk of Cardiovascular Disease and Total Mortality in Adults with Type 1 Diabetes: Scottish Registry Linkage StudyPLOS Medicine, 2012
- Higher plasma high-mobility group box 1 levels are associated with incident cardiovascular disease and all-cause mortality in type 1 diabetes: a 12 year follow-up studyDiabetologia, 2012
- Lipoprotein-Associated Phospholipase A 2 Activity Predicts Progression of Subclinical Coronary AtherosclerosisDiabetes Technology & Therapeutics, 2011
- Association of glycaemia with lipids in adults with type 1 diabetes: modification by dyslipidaemia medicationDiabetologia, 2010
- Temporal patterns in overweight and obesity in Type 1 diabetesDiabetic Medicine, 2010
- Relationship Between Cystatin C and Coronary Artery Atherosclerosis Progression Differs by Type 1 DiabetesDiabetes Technology & Therapeutics, 2010
- Total serum bilirubin does not affect vascular reactivity in patients with diabetesVascular Medicine, 2009
- Network of vascular diseases, death and biochemical characteristics in a set of 4,197 patients with type 1 diabetes (The FinnDiane Study)Cardiovascular Diabetology, 2009
- Predicting cardiovascular risk in England and Wales: prospective derivation and validation of QRISK2BMJ, 2008
- Perturbation of hyaluronan metabolism predisposes patients with type 1 diabetes mellitus to atherosclerosisDiabetologia, 2007